Background: Little is known regarding the impact of socioeconomic factors on the use of evidence-based therapies and outcomes in patients with heart failure with reduced ejection fraction across Asia.Methods: We investigated the association of both patient-level (household income, education levels) and country-level (regional income level by World Bank classification, income disparity by Gini index) socioeconomic indicators on use of guideline-directed therapy and clinical outcomes (composite of 1-year mortality or HF hospitalization, quality of life) in the prospective multinational ASIAN-HF study (Asian Sudden Cardiac Death in Heart Failure).Results: Among 4540 patients (mean age: 60 +/- 13 years, 23% women) with heart failure with reduce...
With increasingly large sample sizes required to demonstrate event reduction, heart failure outcome ...
With increasingly large sample sizes required to demonstrate event reduction, heart failure outcome ...
With increasingly large sample sizes required to demonstrate event reduction, heart failure outcome ...
Background: Little is known regarding the impact of socioeconomic factors on the use of evidence-bas...
Background: Little is known regarding the impact of socioeconomic factors on the use of evidence-bas...
Background: Little is known regarding the impact of socioeconomic factors on the use of evidence-bas...
Background: Little is known regarding the impact of socioeconomic factors on the use of evidence-bas...
Background: Little is known regarding the impact of socioeconomic factors on the use of evidence-bas...
Background: Little is known regarding the impact of socioeconomic factors on the use of evidence-bas...
BackgroundLittle is known regarding the impact of socioeconomic factors on the use of evidence-based...
Background: Data comparing outcomes in heart failure (HF) across Asia are limited. We examined regio...
Background: Data comparing outcomes in heart failure (HF) across Asia are limited. We examined regio...
Aims: Nearly 60% of the World’s population lives in Asia but little is known about the characteristi...
Aims: Nearly 60% of the World’s population lives in Asia but little is known about the characteristi...
With increasingly large sample sizes required to demonstrate event reduction, heart failure outcome ...
With increasingly large sample sizes required to demonstrate event reduction, heart failure outcome ...
With increasingly large sample sizes required to demonstrate event reduction, heart failure outcome ...
With increasingly large sample sizes required to demonstrate event reduction, heart failure outcome ...
Background: Little is known regarding the impact of socioeconomic factors on the use of evidence-bas...
Background: Little is known regarding the impact of socioeconomic factors on the use of evidence-bas...
Background: Little is known regarding the impact of socioeconomic factors on the use of evidence-bas...
Background: Little is known regarding the impact of socioeconomic factors on the use of evidence-bas...
Background: Little is known regarding the impact of socioeconomic factors on the use of evidence-bas...
Background: Little is known regarding the impact of socioeconomic factors on the use of evidence-bas...
BackgroundLittle is known regarding the impact of socioeconomic factors on the use of evidence-based...
Background: Data comparing outcomes in heart failure (HF) across Asia are limited. We examined regio...
Background: Data comparing outcomes in heart failure (HF) across Asia are limited. We examined regio...
Aims: Nearly 60% of the World’s population lives in Asia but little is known about the characteristi...
Aims: Nearly 60% of the World’s population lives in Asia but little is known about the characteristi...
With increasingly large sample sizes required to demonstrate event reduction, heart failure outcome ...
With increasingly large sample sizes required to demonstrate event reduction, heart failure outcome ...
With increasingly large sample sizes required to demonstrate event reduction, heart failure outcome ...
With increasingly large sample sizes required to demonstrate event reduction, heart failure outcome ...